With Academic Collaborators, GSK To Plug For ‘Electroceuticals’

GlaxoSmithKline will fund nonprofit labs across several biomedical and engineering disciplines and offer a $1 million cash prize to probe the role of neural activity in disease. The goal is to build new devices that treat a range of diseases “in their own electrical language.”

Do a web search for the term “electroceuticals,” and many of the results tout a form of alternative medicine. GlaxoSmithKline PLC is angling to make the term a lot more mainstream.

A new funding initiative from the drug giant aims to back academic scientists who are trying to answer early questions...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Combination Products

More from Device Area